AJMC® in the Press, December 22, 2023

A study titled “Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes,” published in the December 2023 issue of The American Journal of Managed Care^® (AJMC^®), was referenced in articles from Physician’s Weekly, DocWire News, and HCPLive. The study found that approximately 40% of patients with type 2 diabetes discontinued their second-line therapies within a year.

An article from Medriva referenced an article published on AJMC.com, the website of AJMC. The article, “Top 5 Conference Coverage of 2023,” collected the most-viewed items on AJMC.com that reported on new research presented at medical conferences that AJMC editors attended throughout the year, including the Annual Meeting of the American Society of Clinical Oncology and the European Hematology Association Congress.